Skin Stripping Should Not Replace Topical Clinical Bioequivalence Studies
Executive Summary
Dermatopharmacokinetic or "skin stripping" tests should not replace comparative clinical trials to demonstrate bioequivalence of topical generic products, FDA's Dermatologic and Ophthalmic Drugs Advisory Committee concluded March 20.